Talphera, Inc.
TLPHTalphera, Inc. is a specialty pharmaceutical company focused on developing and commercializing innovative therapies for use in medically supervised settings, particularly hospitals and intensive care units.
Earnings
Next report
Aug 13, 2026 (in a month)Financials
Q1 2026Valuation & ratios
Competitors
By market cap
By revenue growth
By net margin
Profile
Talphera, Inc. is a specialty pharmaceutical company focused on developing and commercializing innovative therapies for use in medically supervised settings, particularly hospitals and intensive care units. The company's primary value proposition centers on its lead product candidate, Niyad, which is designed to provide regional anticoagulation for patients undergoing continuous renal replacement therapy. Talphera aims to address unmet needs in acute care by offering alternatives to systemic anticoagulants that carry high bleeding risks.
Talphera is a clinical-stage developer seeking to establish a first-mover advantage with the first FDA-approved regional anticoagulant for CRRT. It competes by targeting a significant portion of the market that currently uses no anticoagulation due to safety concerns with existing systemic options.
Questions, answered.
- What is Talphera, Inc.'s market cap?
- Talphera, Inc. (TLPH) has a market capitalization of $70.6M and trades on NASDAQ.
- What is Talphera, Inc.'s revenue and profitability?
- Talphera, Inc. generated $1.0K in trailing twelve-month revenue with a net loss of $14.3M, representing a net margin of -1425300.0%. Gross margin stands at -127.7%. These figures are based on the Q1 2026 filing.
- Who are Talphera, Inc.'s competitors?
- Talphera, Inc.'s key competitors include Baxter International Inc., Fresenius Medical Care, Amphastar Pharmaceuticals, Inc., and others. These companies compete in similar markets and product categories.
- Who does Talphera, Inc. partner with?
- Talphera, Inc.'s notable partners include Alora Pharmaceuticals, LLC, XOMA (US) LLC, Laboratoire Aguettant.
- What subsidiaries does Talphera, Inc. have?
- Talphera, Inc.'s subsidiaries include Lowell Therapeutics, Inc..
- Where is Talphera, Inc. headquartered?
- Talphera, Inc. is headquartered in United States of America and employs approximately 15 people. It has been publicly traded since 2011.
